# 68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

> **NCT01673906** · PHASE2 · COMPLETED · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 142 (actual)

## Conditions studied

- Neuroendocrine Tumours

## Interventions

- **DRUG:** Diagnostic work up

## Key facts

- **NCT ID:** NCT01673906
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-08
- **Final completion:** 2016-07-05
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673906, "68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01673906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*